Absorption of tobramycin from the gut in critically ill patients treated with selective decontamination of the digestive tract (SDD)

Absorption of tobramycin from the gut in critically ill patients treated with selective decontamination of the digestive tract (SDD) - Absorption of tobramycin during SDD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30143

Enrollment

Registered

2006-10-30

Start date

2006-10-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

antibiotics permeability

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Critically ill patients acutely admitted to the intensive care patients, treated with selective decontamination of the digestive tract for at least 24 hours.

Exclusion criteria

Exclusion criteria: Intravenous use of tobramycin or gentamycin

Design outcomes

Primary

Measure	Time frame
concentrations of tobramycin in blood excretion of tobramycin in urine	—

Secondary

Measure	Time frame
renal function SOFA score APACHE score	—

Countries

Netherlands

Outcome results